Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"HBV unIversal vs Point-Of-Care-based Antiviral treatMent to Prevent Mother-to-child Transmission"

NCT07054359 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.

NCT NCT07054359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07054359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"HBV unIversal vs Point-Of-Care-based Antiviral treatMent to Prevent Mother-to-child Transmission"
Lead sponsor
ANRS, Emerging Infectious Diseases
Phase
Not applicable
Overall status
Recruiting
Start date
August 10, 2026
Completion date
November 10, 2029
Enrollment
3,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hbv infection, pregnancy